These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2153827)
1. Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides. Bradbury BJ; Baumgold J; Jacobson KA J Med Chem; 1990 Feb; 33(2):741-8. PubMed ID: 2153827 [TBL] [Abstract][Full Text] [Related]
2. Muscarinic receptor binding and activation of second messengers by substituted N-methyl-N-[4-(1-azacycloalkyl)-2-butynyl]acetamides. Bradbury BJ; Baumgold J; Paek R; Kammula U; Zimmet J; Jacobson KA J Med Chem; 1991 Mar; 34(3):1073-9. PubMed ID: 1848294 [TBL] [Abstract][Full Text] [Related]
3. Conformationally restricted analogues of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide. Lundkvist JR; Ringdahl B; Hacksell U J Med Chem; 1989 Apr; 32(4):863-9. PubMed ID: 2704032 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological differences between muscarinic receptors coupled to phosphoinositide turnover and those coupled to adenylate cyclase inhibition. Baumgold J; White T Biochem Pharmacol; 1989 May; 38(10):1605-16. PubMed ID: 2471534 [TBL] [Abstract][Full Text] [Related]
5. Resolved pyrrolidine, piperidine, and perhydroazepine analogues of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide. Lundkvist JR; Vargas HM; Caldirola P; Ringdahl B; Hacksell U J Med Chem; 1990 Dec; 33(12):3182-9. PubMed ID: 2258904 [TBL] [Abstract][Full Text] [Related]
6. Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists. Fisher SK Mol Pharmacol; 1988 Apr; 33(4):414-22. PubMed ID: 3357485 [TBL] [Abstract][Full Text] [Related]
7. Urea and 2-imidazolidone derivatives of the muscarinic agents oxotremorine and N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide. Nilsson BM; Vargas HM; Hacksell U J Med Chem; 1992 Aug; 35(17):3270-9. PubMed ID: 1507212 [TBL] [Abstract][Full Text] [Related]
8. An agonist that is selective for adenylate cyclase-coupled muscarinic receptors. Baumgold J; Drobnick A Mol Pharmacol; 1989 Sep; 36(3):465-70. PubMed ID: 2550780 [TBL] [Abstract][Full Text] [Related]
9. Relationship between agonist-induced muscarinic receptor loss and desensitization of stimulated phosphoinositide turnover in two neuroblastomas: methodological considerations. Thompson AK; Fisher SK J Pharmacol Exp Ther; 1990 Feb; 252(2):744-52. PubMed ID: 2156059 [TBL] [Abstract][Full Text] [Related]
10. Functionalized congener approach to muscarinic antagonists: analogues of pirenzepine. Karton Y; Bradbury BJ; Baumgold J; Paek R; Jacobson KA J Med Chem; 1991 Jul; 34(7):2133-45. PubMed ID: 2066986 [TBL] [Abstract][Full Text] [Related]
11. Chemical and biochemical studies of 2-propynylpyrrolidine derivatives. Restricted-rotation analogues of N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide (BM-5). Trybulski EJ; Kramss RH; Mangano RM; Rusinko A J Med Chem; 1990 Dec; 33(12):3190-8. PubMed ID: 2258905 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and muscarinic activities of 1,2,4-thiadiazoles. MacLeod AM; Baker R; Freedman SB; Patel S; Merchant KJ; Roe M; Saunders J J Med Chem; 1990 Jul; 33(7):2052-9. PubMed ID: 2362286 [TBL] [Abstract][Full Text] [Related]
13. Characterization of muscarinic agonists in recombinant cell lines. Schwarz RD; Davis RE; Jaen JC; Spencer CJ; Tecle H; Thomas AJ Life Sci; 1993; 52(5-6):465-72. PubMed ID: 8382764 [TBL] [Abstract][Full Text] [Related]
14. Derivatives of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide. Nilsson BM; Ringdahl B; Hacksell U J Med Chem; 1988 Mar; 31(3):577-82. PubMed ID: 3346873 [TBL] [Abstract][Full Text] [Related]
15. Relationship between desensitization and sequestration of muscarinic cholinergic receptors in two neuronal cell lines. Baumgold J; Cooperman BB; White TM Neuropharmacology; 1989 Nov; 28(11):1253-61. PubMed ID: 2556656 [TBL] [Abstract][Full Text] [Related]
16. Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes. Sharif NA; Williams GW; DeSantis LM Neurochem Res; 1995 Jun; 20(6):669-74. PubMed ID: 7566362 [TBL] [Abstract][Full Text] [Related]
17. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations. McKinney M; Stenstrom S; Richelson E Mol Pharmacol; 1985 Feb; 27(2):223-35. PubMed ID: 2982089 [TBL] [Abstract][Full Text] [Related]
18. Regulation of muscarinic cholinergic receptor density in neuroblastoma cells by brief exposure to agonist: possible involvement in desensitization of receptor function. Feigenbaum P; El-Fakahany EE J Pharmacol Exp Ther; 1985 Apr; 233(1):134-40. PubMed ID: 3981451 [TBL] [Abstract][Full Text] [Related]
19. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells. Lazareno S; Buckley NJ; Roberts FF Mol Pharmacol; 1990 Dec; 38(6):805-15. PubMed ID: 2250662 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of agonist-induced down-regulation and subsequent recovery of muscarinic acetylcholine receptors in a clonal neuroblastoma x glioma hybrid cell line. Ray P; Middleton W; Berman JD J Neurochem; 1989 Feb; 52(2):402-9. PubMed ID: 2562988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]